Rx Prescription Required

Composition: Ceftriaxone 500mg & Tazobactam 62.5 mg

Dosage form: Dry powder for Injection

Packing: 562.5mg vial with 30 ml WFI

storage: Store in a cool and dry place below 30°C

Third-Party Manufacturing | Wholesale Supply | PCD Franchise

Product Introduction

RAVICEF-TZ Injection is a broad-spectrum antibiotic formulation containing Ceftriaxone Sodium IP equivalent to Ceftriaxone 500 mg and Tazobactam Sodium equivalent to Tazobactam 62.5 mg. This combination is widely used in the management of moderate to severe bacterial infections caused by susceptible microorganisms.

Ceftriaxone is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, while Tazobactam is a beta-lactamase inhibitor that enhances the effectiveness of Ceftriaxone against resistant bacteria. Together, they provide extended antibacterial coverage and improved clinical outcomes

Uses

Ravicef-TZ Injection is commonly indicated for the treatment of:

• Respiratory tract infections
• Pneumonia and bronchitis
• Urinary tract infections (UTIs)
• Skin and soft tissue infections
• Intra-abdominal infections
• Bone and joint infections

Benefits

• Enhanced Antibacterial Coverage

• Effective Against Severe Infections

• Improved Clinical Response

• Convenient Administration

• Dosage and Administration

Side Effects

Some individuals may experience mild side effects such as

• Pain or redness at the injection site
• Nausea
• Vomiting
• Diarrhea
• Headache

B2B Commercial Advantages

RAVICEF-TZ Injection are available for:

• Pharma distributors
• Medical wholesalers
• PCD pharma franchise partners
• Hospital and institutional supply
• Third-party pharma marketing companies

Bulk supply with competitive pricing and consistent quality assurance.